Has Jinu John, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,129 in general payments to Jinu John, MD across 93 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jinu John, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jinu John, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jinu John, MD

Cardiovascular Disease · Manchester, NHNPI 1467682369

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $7,716 of the $12,129 with a category attached, or 63.6%. Abbott accounts for 79.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $5,437 and has fallen 91.7% since, to $451 in 2025. Among cardiovascular disease clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,129in general payments, 2019–2025

Across 93 payments — averaging $130.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$10K
Boston Scientific$2K
Biotronik Inc.$266
Biosense Webster, Inc.$258
Medtronic$122
Novartis$64
plus $53 from 3 others

$119,005in research payments, 2019–2025

Across 39 payments — averaging $3051.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$105K
Medtronic$14K

What the payments were for

Consulting fees$1,22010%
Travel & lodging$7,71664%
Food & beverage$3,19326%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	60	$9,589
Boston Scientific	19	$1,777
Biotronik Inc.	3	$266
Biosense Webster, Inc.	3	$258
Medtronic(2 entities)	3	$122
Novartis	2	$64
AstraZeneca	1	$28
Cardiva Medical, Inc.	1	$15
Altathera Pharmaceuticals LLC	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,129 in reported general payments places this provider in the 90th percentile of 112 cardiovascular disease providers in New Hampshire.

See all cardiovascular disease providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$310,015

Medicare patients

2,328

Services billed

4,810

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	355	$393,659
XareltoRivaroxaban	69	$68,888
Dofetilide	33	$6,577
Mexiletine Hcl	54	$6,529
Metoprolol Succinate	348	$5,574
Flecainide Acetate	36	$2,296
Diltiazem 24hr Er (Cd)Diltiazem Hcl	59	$1,129
Amiodarone Hcl	42	$785
ClopidogrelClopidogrel Bisulfate	50	$743
SotalolSotalol Hcl	52	$645
Potassium Chloride	23	$517
Atorvastatin Calcium	80	$509
Torsemide	12	$436
Furosemide	87	$401
Digoxin	13	$381

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Manchester

Fahad GilaniManchester$418K
Stephan HeoManchester$116K
Robert CapodilupoManchester$85K
Jeanney LewManchester$36K
Michelle OuelletteManchester$7K
Patrick HickleManchester$5K
Jeffrey BleakleyManchester$5K
Tong ZhuManchester$4K
Alan GarstkaManchester$3K
Stephen HanlonManchester$3K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →